Anhui Anke Biotechnology | Ownership
Companies that own Anhui Anke Biotechnology
AEGON-INDUSTRIAL Fund Management Co., Ltd.
15,734,673
2.4%
8,378,038
0.59%
12/31/2017
Penghua Fund Management Co., Ltd.
9,411,959
1.44%
9,411,959
0.2%
09/30/2017
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)
8,622,265
1.32%
-14,353,793
0.47%
09/30/2017
Fullgoal Fund Management Co., Ltd.
6,667,730
1.02%
-7,927,759
0.14%
12/31/2017
China Universal Asset Management Co., Ltd.
6,160,083
0.94%
-1,159,657
0.11%
09/30/2017
E Fund Management Co., Ltd.
4,557,231
0.7%
-289,100
0.07%
12/31/2017
China Asset Management Co., Ltd.
4,408,477
0.67%
4,408,477
0.05%
12/31/2017
Baoying Fund Management Co., Ltd.
4,346,521
0.66%
2,708,521
0.36%
12/31/2017
AXA-SPDB Investment Managers Co., Ltd.
2,394,848
0.37%
2,393,399
0.57%
12/31/2017
Bosera Asset Management Co., Ltd.
2,100,120
0.32%
2,100,120
0.04%
12/31/2017
| Address |
K-1, Haiguan Road
Hefei Anhui 230088
China
|
|
Employees
|
- |
| Website |
http://www.ankebio.com |
| Updated |
07/08/2019 |
| Anhui Anke Biotechnology (Group) Co., Ltd. engages in the research and development, manufacture, and sale of biopharmaceutical products. Its business activities include implementation of precision medical development strategy, formation of genetic testing, and development of anti-tumor drugs and cell immunotherapy technology. Its products consist of biological products, modern Chinese medicine, chemical synthetic drugs, peptide active pharmaceutical ingredients, nucleic acid detection, and cosmetic products. |
